| scholarly article | Q13442814 |
| P2093 | author name string | H Liu | |
| H Xiao | |||
| X Wu | |||
| J C Kappes | |||
| G V Kalpana | |||
| V Prasad | |||
| J A Conway | |||
| E Hehl | |||
| P2860 | cites work | Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5 | Q24336208 |
| The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells | Q24564509 | ||
| Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition | Q24673418 | ||
| Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases | Q27730298 | ||
| HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase | Q28291170 | ||
| HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro | Q28303975 | ||
| Retroviral integration: structure of the initial covalent product and its precursor, and a role for the viral IN protein | Q28646798 | ||
| Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection | Q28646834 | ||
| Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene | Q29615351 | ||
| Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B | Q29618922 | ||
| Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein | Q33887338 | ||
| Complementation of integrase function in HIV-1 virions. | Q33887343 | ||
| Retroviral DNA integration: Structure of an integration intermediate | Q34177650 | ||
| Functional association of cyclophilin A with HIV-1 virions | Q34326356 | ||
| Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase | Q34577497 | ||
| Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells | Q35829884 | ||
| Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication | Q35838477 | ||
| Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. | Q35839628 | ||
| Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell | Q35840793 | ||
| Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis | Q35845204 | ||
| The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. | Q35851966 | ||
| Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. | Q35854265 | ||
| Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles | Q35860937 | ||
| Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription | Q35861172 | ||
| Expression of human immunodeficiency virus type 1 reverse transcriptase in trans during virion release and after infection | Q35861729 | ||
| Human immunodeficiency virus Type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA(Lys3) in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site | Q35865776 | ||
| Characterization of human immunodeficiency virus type 1 Vif particle incorporation | Q35868144 | ||
| Lack of integrase can markedly affect human immunodeficiency virus type 1 particle production in the presence of an active viral protease | Q35870149 | ||
| Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase. | Q35882489 | ||
| Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA. | Q35888060 | ||
| Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein. | Q35895836 | ||
| Binding and kinetic properties of HIV-1 reverse transcriptase markedly differ during initiation and elongation of reverse transcription. | Q35917913 | ||
| Genetic analysis of the human immunodeficiency virus type 1 integrase protein. | Q36629409 | ||
| Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells | Q36651389 | ||
| Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1 | Q36654022 | ||
| Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. | Q36684088 | ||
| Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro | Q36684957 | ||
| Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity | Q36685270 | ||
| Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases | Q36815395 | ||
| Murine leukemia virus pol gene products: analysis with antisera generated against reverse transcriptase and endonuclease fusion proteins expressed in Escherichia coli. | Q36883944 | ||
| Mutational analysis of the integrase protein of human immunodeficiency virus type 2 | Q37245763 | ||
| Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain | Q38290032 | ||
| Specific incorporation of cyclophilin A into HIV-1 virions | Q38302257 | ||
| Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations. | Q38322937 | ||
| Tat is required for efficient HIV-1 reverse transcription | Q38347693 | ||
| Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His). | Q38362410 | ||
| Human T-cell leukemia virus type 1 reverse transcriptase (RT) originates from the pro and pol open reading frames and requires the presence of RT-RNase H (RH) and RT-RH-integrase proteins for its activity. | Q39579463 | ||
| Conserved sequences in the carboxyl terminus of integrase that are essential for human immunodeficiency virus type 1 replication | Q39873244 | ||
| Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. | Q39880513 | ||
| The retroviral enzymes | Q40394916 | ||
| The human immunodeficiency virus integrase protein | Q40721717 | ||
| Two bases are deleted from the termini of HIV-1 linear DNA during integrative recombination | Q44042137 | ||
| Site-directed mutagenesis of HIV-1 integrase demonstrates differential effects on integrase functions in vitro | Q44696814 | ||
| Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation. | Q45770989 | ||
| Subunit-selective mutagenesis of Glu-89 residue in human immunodeficiency virus reverse transcriptase. Contribution of p66 and p51 subunits to nucleoside analog sensitivity, divalent cation preference, and steady state kinetic properties. | Q45789871 | ||
| Identification of amino acid residues critical for endonuclease and integration activities of HIV-1 IN protein in vitro | Q54677992 | ||
| Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNA(3Lys) (template/primer) | Q72134543 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 2126-2135 | |
| P577 | publication date | 1999-03-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex | |
| P478 | volume | 73 |
| Q34249167 | A critical role of the C-terminal segment for allosteric inhibitor-induced aberrant multimerization of HIV-1 integrase |
| Q37780981 | A new functional role of HIV-1 integrase during uncoating of the viral core |
| Q24815183 | A novel function for spumaretrovirus integrase: an early requirement for integrase-mediated cleavage of 2 LTR circles |
| Q28483813 | A symmetric region of the HIV-1 integrase dimerization interface is essential for viral replication |
| Q35046515 | Allosteric inhibitor development targeting HIV-1 integrase |
| Q34059119 | Altered viral fitness and drug susceptibility in HIV-1 carrying mutations that confer resistance to nonnucleoside reverse transcriptase and integrase strand transfer inhibitors |
| Q33935269 | Analysis of human immunodeficiency virus type 1 reverse transcriptase subunit structure/function in the context of infectious virions and human target cells |
| Q33780519 | Analysis of the contribution of reverse transcriptase and integrase proteins to retroviral RNA dimer conformation |
| Q30885857 | Augmentation of reverse transcription by integrase through an interaction with host factor, SIP1/Gemin2 Is critical for HIV-1 infection |
| Q92675301 | Binding interface and impact on protease cleavage for an RNA aptamer to HIV-1 reverse transcriptase |
| Q39604854 | Biochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6(Gag). |
| Q30157084 | Biochemical and virological analysis of the 18-residue C-terminal tail of HIV-1 integrase. |
| Q64106198 | Cellular TRIM33 restrains HIV-1 infection by targeting viral integrase for proteasomal degradation |
| Q36169613 | Characterization of HIV-1 integrase N-terminal mutant viruses |
| Q40275247 | Class II integrase mutants with changes in putative nuclear localization signals are primarily blocked at a postnuclear entry step of human immunodeficiency virus type 1 replication |
| Q34163065 | Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding |
| Q39915711 | Contribution of the C-terminal region within the catalytic core domain of HIV-1 integrase to yeast lethality, chromatin binding and viral replication |
| Q24814060 | Contribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear import |
| Q38499684 | Cooperation between reverse transcriptase and integrase during reverse transcription and formation of the preintegrative complex of Ty1. |
| Q41841102 | Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus |
| Q37512925 | Critical Contribution of Tyr15 in the HIV-1 Integrase (IN) in Facilitating IN Assembly and Nonenzymatic Function through the IN Precursor Form with Reverse Transcriptase |
| Q39825383 | Cross-packaging of genetically distinct mouse and primate retroviral RNAs |
| Q40551545 | Cross-packaging of human immunodeficiency virus type 1 vector RNA by spleen necrosis virus proteins: construction of a new generation of spleen necrosis virus-derived retroviral vectors |
| Q36571812 | Drug Susceptibility and Viral Fitness of HIV-1 with Integrase Strand Transfer Inhibitor Resistance Substitution Q148R or N155H in Combination with Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Resistance Substitutions |
| Q37333915 | Functional analysis of N-terminal residues of ty1 integrase |
| Q35826158 | Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages |
| Q26746070 | HIV Genome-Wide Protein Associations: a Review of 30 Years of Research |
| Q38124090 | HIV integrase inhibitors: 20-year landmark and challenges |
| Q28538038 | HIV-1 Nef inhibits Protease activity and its absence alters protein content of mature viral particles |
| Q37689513 | HIV-1 Vpr-a still "enigmatic multitasker". |
| Q38380688 | HIV-1 integrase multimerization as a therapeutic target |
| Q35069785 | HIV-1 replication in cell lines harboring INI1/hSNF5 mutations. |
| Q27023387 | HIV-1 reverse transcription |
| Q37430491 | HIV-1-associated PKA acts as a cofactor for genome reverse transcription |
| Q33845811 | Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells |
| Q35076592 | Human immunodeficiency virus type 1 and related primate lentiviruses engage clathrin through Gag-Pol or Gag. |
| Q33838354 | Human immunodeficiency virus type 1 central DNA flap: dynamic terminal product of plus-strand displacement dna synthesis catalyzed by reverse transcriptase assisted by nucleocapsid protein |
| Q37004198 | INI1/hSNF5-interaction defective HIV-1 IN mutants exhibit impaired particle morphology, reverse transcription and integration in vivo |
| Q42186812 | Identification of a novel human immunodeficiency virus type 1 integrase interactor, Gemin2, that facilitates efficient viral cDNA synthesis in vivo |
| Q37134432 | Identifying and characterizing a functional HIV-1 reverse transcriptase-binding site on integrase |
| Q35063298 | Impairment of human immunodeficiency virus type-1 integrase SUMOylation correlates with an early replication defect |
| Q37320835 | In vivo manipulation of gene expression in non-human primates using lentiviral vectors as delivery vehicles |
| Q35857486 | Incorporation of human immunodeficiency virus type 1 reverse transcriptase into virus-like particles |
| Q58751688 | Induction of HIF-1α by HIV-1 Infection in CD4 T Cells Promotes Viral Replication and Drives Extracellular Vesicle-Mediated Inflammation |
| Q43000887 | Inhibition of the integrases of human immunodeficiency viruses type 1 and type 2 by reverse transcriptases |
| Q28359887 | Inhibitors of human immunodeficiency virus type 1 reverse transcriptase target distinct phases of early reverse transcription |
| Q37353201 | Integrase and integration: biochemical activities of HIV-1 integrase |
| Q37232867 | Integrase interacts with nucleoporin NUP153 to mediate the nuclear import of human immunodeficiency virus type 1 |
| Q33812392 | Integrase-lexA fusion proteins incorporated into human immunodeficiency virus type 1 that contains a catalytically inactive integrase gene are functional to mediate integration |
| Q36281118 | Interaction between Reverse Transcriptase and Integrase Is Required for Reverse Transcription during HIV-1 Replication |
| Q40814997 | Interaction between human immunodeficiency virus type 1 reverse transcriptase and integrase proteins |
| Q36098878 | Molecular mechanisms by which human immunodeficiency virus type 1 integrase stimulates the early steps of reverse transcription |
| Q33849672 | Moloney murine leukemia virus integrase protein augments viral DNA synthesis in infected cells |
| Q92992903 | Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition |
| Q26795766 | Multifunctional facets of retrovirus integrase |
| Q37574479 | Multimodal mechanism of action of allosteric HIV-1 integrase inhibitors |
| Q41533374 | Mutations affecting interaction of integrase with TNPO3 do not prevent HIV-1 cDNA nuclear import |
| Q36538644 | Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro |
| Q33911895 | Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer |
| Q27678745 | New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action |
| Q38081866 | Next-generation integrase inhibitors : where to after raltegravir? |
| Q34226132 | Non-Enzymatic Functions of Retroviral Integrase: The Next Target for Novel Anti-HIV Drug Development |
| Q35942573 | Non-POU Domain-Containing Octamer-Binding Protein Negatively Regulates HIV-1 Infection in CD4(+) T Cells |
| Q64087409 | Noncovalent SUMO-interaction motifs in HIV integrase play important roles in SUMOylation, cofactor binding, and virus replication |
| Q37083719 | Posttranslational modifications of HIV-1 integrase by various cellular proteins during viral replication |
| Q33816738 | Proteolytic activity, the carboxy terminus of Gag, and the primer binding site are not required for Pol incorporation into foamy virus particles |
| Q33463283 | Recruitment of a SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral replication |
| Q35607763 | Reduced viral fitness and lack of cross-class resistance with integrase strand transfer inhibitor and nucleoside reverse transcriptase inhibitor resistance mutations |
| Q36473812 | Replication of chimeric human immunodeficiency virus type 1 (HIV-1) containing HIV-2 integrase (IN): naturally selected mutations in IN augment DNA synthesis. |
| Q30341397 | Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase. |
| Q28596842 | Retroviral DNA Integration |
| Q35249277 | Retroviral DNA Transposition: Themes and Variations |
| Q28073156 | Retroviral Integrase: Then and Now |
| Q37722585 | Retroviral reverse transcriptases |
| Q33257614 | Revealing domain structure through linker-scanning analysis of the murine leukemia virus (MuLV) RNase H and MuLV and human immunodeficiency virus type 1 integrase proteins |
| Q35260021 | Reverse Transcriptase and Cellular Factors: Regulators of HIV-1 Reverse Transcription. |
| Q51003294 | Reverse Transcription of Retroviruses and LTR Retrotransposons. |
| Q33826918 | Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core |
| Q41827820 | Role of integrase in reverse transcription of the Saccharomyces cerevisiae retrotransposon Ty1. |
| Q39582953 | Sequential deletion of the integrase (Gag-Pol) carboxyl terminus reveals distinct phenotypic classes of defective HIV-1. |
| Q35956555 | Signals in APOBEC3F N-terminal and C-terminal deaminase domains each contribute to encapsidation in HIV-1 virions and are both required for HIV-1 restriction |
| Q24307975 | Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance |
| Q31115387 | Structural and functional role of INI1 and LEDGF in the HIV-1 preintegration complex |
| Q30009248 | Structural dynamics of native and V260E mutant C-terminal domain of HIV-1 integrase |
| Q40883677 | Styrylquinolines, integrase inhibitors acting prior to integration: a new mechanism of action for anti-integrase agents |
| Q34339757 | Subcellular localization and integration activities of rous sarcoma virus reverse transcriptase |
| Q34438247 | Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo. |
| Q33821401 | Targeting human immunodeficiency virus (HIV) type 2 integrase protein into HIV type 1. |
| Q39545432 | The 156KELK159 tetrapeptide of HIV-1 integrase is critical for lentiviral gene integration |
| Q47735179 | The HIV-1 Nef protein enhances the affinity of reverse transcriptase for RNA in vitro. |
| Q37027897 | The N-end rule and retroviral infection: no effect on integrase |
| Q33864450 | The RNA binding protein HuR does not interact directly with HIV-1 reverse transcriptase and does not affect reverse transcription in vitro |
| Q21245211 | The Vpr protein from HIV-1: distinct roles along the viral life cycle |
| Q35215018 | The allosteric HIV-1 integrase inhibitor BI-D affects virion maturation but does not influence packaging of a functional RNA genome |
| Q39402465 | The cellular antiviral protein APOBEC3G interacts with HIV-1 reverse transcriptase and inhibits its function during viral replication |
| Q37110732 | The chromodomain of Tf1 integrase promotes binding to cDNA and mediates target site selection |
| Q42932779 | The combined anti-HIV-1 activities of emtricitabine and tenofovir plus the integrase inhibitor elvitegravir or raltegravir show high levels of synergy in vitro |
| Q34999802 | The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein. |
| Q33676449 | The foamy virus genome remains unintegrated in the nuclei of G1/S phase-arrested cells, and integrase is critical for preintegration complex transport into the nucleus |
| Q39592447 | The karyophilic properties of human immunodeficiency virus type 1 integrase are not required for nuclear import of proviral DNA. |
| Q35023991 | The self primer of the long terminal repeat retrotransposon Tf1 is not removed during reverse transcription |
| Q41860319 | Transcription factor YY1 interacts with retroviral integrases and facilitates integration of moloney murine leukemia virus cDNA into the host chromosomes |
| Q34332190 | Ty3 integrase is required for initiation of reverse transcription |
| Q35962942 | von Hippel Lindau binding protein 1-mediated degradation of integrase affects HIV-1 gene expression at a postintegration step |
Search more.